GS-441524 is a nucleoside analog compound that has gained attention in veterinary antiviral research. It is commonly referenced in treatment programs related to feline infectious peritonitis (FIP), a disease caused by mutations of feline coronavirus.
This product is provided as an injectable formulation intended for veterinary use and professional management programs. The compound is known for its stable chemical properties and is used within structured dosing protocols developed by veterinarians and animal health specialists.
The injectable form allows direct systemic absorption, which can be beneficial when consistent dosing and reliable bioavailability are required during long-term treatment cycles.
| Parameter | Specification |
|---|---|
| Product Name | GS-441524 |
| CAS Number | 1191237-69-0 |
| Dosage Form | Injection |
| Strength | 20mg / 30mg |
| Packaging | 6ml / vial, 8ml / vial, 10ml / vial |
| Storage Condition | Room Temperature |
| Shelf Life | 1 Year from Date of Manufacture |
| Country of Manufacture | China |
| Main Function |
Treatment for Cat FIP |
Each vial is sealed and labeled to ensure batch traceability and safe transportation.
Feline infectious peritonitis (FIP) is a viral disease affecting cats and is considered one of the more serious conditions in feline medicine. It develops when feline coronavirus mutates inside the host and triggers systemic infection.
There are generally two primary clinical forms:
Wet (Effusive) FIP
Characterized by fluid accumulation in the abdomen or chest.
Dry (Non-effusive) FIP
More chronic in nature and may involve organs such as the liver, kidneys, or lymph nodes.
In some cases, the disease can also affect the eyes or nervous system, which may require adjusted dosing strategies during treatment planning.
Treatment programs are usually calculated based on the cat’s body weight and the specific clinical presentation.
The following dosage references are commonly used in FIP treatment protocols:
| Condition | Recommended Dose |
|---|---|
| Wet FIP | 0.3 ml / kg body weight + 0.1 ml residue |
| Dry FIP | 0.4 ml / kg body weight + 0.1 ml residue |
| Eye or Nerve Involvement | 0.5 ml / kg body weight + 0.1 ml residue |
| Recurrence Cases | 0.6 ml / kg body weight + 0.1 ml residue |
During the treatment period, body weight should be monitored regularly so the dosage can be adjusted if necessary.
Several characteristics make GS-441524 injectable formulations suitable for veterinary management programs:
Stable injectable formulation
Two available concentration options (20mg and 30mg)
Multiple vial sizes to support different treatment cycles
Room temperature storage convenience
Clearly labeled packaging with batch identification
These features make the product easier to handle for veterinary clinics, distributors, and animal care organizations.
To maintain product quality:
Store at room temperature in a dry place
Avoid excessive heat or direct sunlight
Keep vials sealed until use
Use sterile technique during administration
Under appropriate storage conditions, the product maintains stability for up to 12 months from the manufacturing date.
Different vial sizes are available to meet the needs of various treatment plans:
6ml vial
8ml vial
10ml vial
Flexible packaging helps reduce waste and allows veterinarians to plan treatment courses more efficiently depending on the cat’s weight and duration of therapy.
GS-441524 injection is commonly supplied to:
Veterinary clinics
Animal hospitals
Cat rescue organizations
Veterinary pharmaceutical distributors
It is intended for professional veterinary use and should be administered according to appropriate treatment guidelines.
This product is intended for veterinary use only.
Treatment plans and dosing decisions should always be determined by qualified veterinary professionals based on clinical evaluation.
